Author

Nina Gabelia

ORCID 0009-0001-8375-9148Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Anton WellsteiniD· 1 shared Gerry MelinoiD· 1 shared Hartmut Juhl· 1 shared Jobst LandgrebeiD· 1 shared John Lindsay MarshalliD· 1 shared Nithya Raman· 1 shared Silvia von der Heyde· 1 shared Takayuki YoshinoiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anton WellsteinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tumour specimen cold ischemia time impacts molecular cancer drug target discovery

Silvia von der Heyde, Nithya Raman, Nina Gabelia, Xavier Matías‐Guiu, Takayuki Yoshino, Yuichiro Tsukada, Gerry Melino, John Lindsay Marshall, Anton Wellstein, Hartmut Juhl, Jobst Landgrebe

This study shows that cold ischemia time significantly affects molecular profiles in tumor and normal tissues, impacting drug target discovery.

Cell Death and Disease · Sep 26, 2024Peer-reviewedCancer Biology